SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2213-2600(21)00542-7
PubMed Identifier: 35085490
Publication URI: http://europepmc.org/abstract/MED/35085490
Type: Journal Article/Review
Parent Publication: The Lancet Respiratory Medicine
Issue: 4
ISSN: 2213-2600